about
Histamine N-methyltransferaseErythropoietinSynuclein, alphaAmyloid beta (A4) precursor proteinCD38 antigenTumor necrosis factor receptor superfamily, member 11a, NFKB activatorMyeloid differentiation primary response gene 88Solute carrier family 30 (zinc transporter), member 8ANXA1Annexin A1Protein kinase C, alphaInterleukin 1 receptor antagonistInterleukin 1 betaMYD88 innate immune signal transduction adaptorV-rel reticuloendotheliosis viral oncogene homolog A (avian)Protein kinase C iotaSRC proto-oncogene, non-receptor tyrosine kinaseCytochrome b-245 alpha chainReceptor interacting serine/threonine kinase 2ETS proto-oncogene 1, transcription factorInterleukin 1 receptor associated kinase 2Cbp/p300 interacting transactivator with Glu/Asp rich carboxy-terminal domain 1Tripartite motif containing 63Chitinase 3 like 1Interleukin 1 receptor type 1Immunoglobulin binding protein 1YTH domain containing 2Glutamate-cysteine ligase catalytic subunitTLE family member 5, transcriptional modulatorHistone deacetylase 4Interleukin 1 receptor associated kinase 1Interleukin 1 receptor associated kinase 3Galectin 9TATA-box binding protein associated factor 9Chitinase-like 1Interleukin 1 receptor, type IHistamine N-methyltransferaseTLE family member 5, transcriptional modulatorTNF receptor-associated factor 6Cbp/p300-interacting transactivator with Glu/Asp-rich carboxy-terminal domain 1
P682
IRAK-M is a novel member of the Pelle/interleukin-1 receptor-associated kinase (IRAK) familyCytokine activation of p38 mitogen-activated protein kinase and apoptosis is opposed by alpha-4 targeting of protein phosphatase 2A for site-specific dephosphorylation of MEK3.Constitutive and interleukin-1-inducible phosphorylation of p65 NF-{kappa}B at serine 536 is mediated by multiple protein kinases including I{kappa}B kinase (IKK)-{alpha}, IKK{beta}, IKK{epsilon}, TRAF family member-associated (TANK)-binding kinaseUpregulation of alpha-synuclein by lipopolysaccharide and interleukin-1 in human macrophagesActivation of ROS/NF-kappaB and Ca2+/CaM kinase II are necessary for VCAM-1 induction in IL-1beta-treated human tracheal smooth muscle cellsSite-specific Lys-63-linked tumor necrosis factor receptor-associated factor 6 auto-ubiquitination is a critical determinant of I kappa B kinase activationLeukocyte adhesion to vascular endothelium induces E-selectin linkage to the actin cytoskeletonInflammatory cytokines induce production of CHI3L1 by articular chondrocytesMiR-204 enhances the progression of osteoarthritis by suppressing the production of IL-1β.
P921
Q1085773-C8B1E680-DC97-4576-9FED-DFF165EB6E1AQ14852044-ABF94D70-6FC8-4852-B5E9-8D2F905AEA93Q14862284-424DBB03-F127-49A5-A1FB-ADA301FA1922Q14865884-2507FA38-743B-4841-8127-EFE4658AF5B3Q14865884-CACB4ADA-7666-436C-9BE6-B043C8564005Q14885138-AE456E06-6E5F-402D-A53C-0A9B15CF001EQ14900987-72CB30D4-2082-4998-AF89-11460DB1DA0AQ14905922-48E95717-E3FD-4CCE-A23B-A2D780F09539Q14907993-79C3EA65-8061-4DD3-8919-6975C4D7DC2EQ14908222-9BB94B26-E45B-45C3-B268-B972976C303BQ14908226-1DF80E10-9BEC-4275-A0A5-3D5F4E6EECBDQ14908226-CC8CAAB7-0D49-46A6-AF2E-68D408A5285EQ14912658-E0978A0D-C533-435F-9B3E-0390356CA6CDQ14914160-3CA2262A-1261-4A83-88C8-EC81A10DB138Q14916414-B82C3AD4-0C46-4188-AB71-2CAD10CBA74CQ14916414-FD2291B9-1201-47EA-877E-502596501EA9Q1500000-DD1EB801-D3C4-43B4-9F1F-30914A03FE60Q15326089-B25942A7-6ED9-43EE-A439-71A15331953CQ21109253-DCAF8AB6-915A-4F68-B0C6-CF5186B7F624Q21109354-8F13258C-AD2A-4906-912A-14132D427F95Q21109992-5A13405F-2447-4D80-B355-6CDBB317764EQ21111679-89758D4A-A832-458A-A196-A15D2E787AE8Q21116585-7342840D-0254-4610-96D6-B4E28D077CE3Q21116618-472D974E-3CD9-46A7-B7CD-4B521F761B07Q21116830-6067D81F-B6E5-4052-A9F4-531822E3100CQ21117056-A183F124-FEF5-4EDA-979B-D9ACE4AAE03DQ21117210-8AEAB8B4-F9E0-4809-A3DC-0D6E9D692305Q21117797-019FC885-E6A7-4777-A3C4-1E4DC176EA4AQ21118373-5C8F0E29-A874-4899-8AD4-F6343CDCCC21Q21118457-E2E9BCEA-4D99-4539-9989-EBB653D788E9Q21119010-A5556C5F-48FB-41FA-91EC-8896D47F2BD7Q21139116-48DDB9F2-79A7-48C0-A279-2916AC985764Q21173206-9CDDB532-80A5-42EE-A92A-3074406D8E3FQ21173372-26A016CB-E5B7-44AB-9BB9-DF763D22F390Q21173769-C192B4FD-10EF-4FF0-83C6-26E807E2CF96Q21173945-0EDBD051-6610-455C-868F-5A9C98A8E36FQ21201605-572BEE65-02A8-40A1-A093-5E786943FAE3Q21494180-337E75AD-07D8-4058-9E90-DCB2207655DFQ21495868-DF0CF675-FAD2-4201-89DD-3525C8040EE0Q21496458-F958EE30-4B96-4F00-B21B-87C7541921F7
P682
Q22010176-58C58404-6200-4100-A280-3A97396E6168Q24302542-26D52249-EE7F-4F32-A29D-AFBFD6D0FA74Q24307395-3C4F5AFD-C77E-4A0D-B15D-D0E0A1017D2FQ24314013-B7C3DA39-B0A0-4141-BC50-A7BE3CD623DBQ24321220-FE48996D-C700-4B47-BCCF-7E1E467F35A1Q24321363-2392CF06-0D54-4937-901A-CB31614A5C66Q24324356-CCCD4B0A-AB3E-412B-849B-0F5ADB376791Q24338555-15CD5018-356E-45DA-AE86-6B38A457F9FAQ50018650-611876A0-C7C4-45B4-91DE-E7D219499474
P921
description
Any process that results in a ...... of an interleukin-1 stimulus.
@en
biologisch proces
@nl
name
response tae interleukin-1
@sco
response to interleukin-1
@en
răspuns la interleukina-1
@ro
type
label
response tae interleukin-1
@sco
response to interleukin-1
@en
răspuns la interleukina-1
@ro
altLabel
GO:0070555
@en
response to IL-1
@en
răspuns la IL-1
@ro
prefLabel
response tae interleukin-1
@sco
response to interleukin-1
@en
răspuns la interleukina-1
@ro
P2888
P686
GO:0070555